Pfizer Lowers 2013 Forecast After Drug Sales Miss Estimates

Pfizer Lowers 2013 Forecast After Drug Sales Miss Estimates

Peter Foley/Bloomberg

Pfizer Inc. has been working to remake itself after it lost exclusive sales rights to Lipitor in 2011, the anti-cholesterol pill that was once the world’s top-selling medicine with almost $13 billion.